The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Open accessAbstract
Primary bile acids serve important roles in cholesterol metabolism, lipid digestion, host-microbe interactions, and regulatory pathways in the human host. While most bile acids are reabsorbed and recycled via enterohepatic cycling, ∼5% serve as substrates for bacterial biotransformation in the colon. Enzymes involved in various transformations have been characterized from cultured gut bacteria and reveal taxa-specific distribution. More recently, bioinformatic approaches have revealed greater diversity in isoforms of these enzymes, and the microbial species in which they are found. Thus, the functional roles played by the bile acid-transforming gut microbiota and the distribution of resulting secondary bile acids, in the bile acid pool, may be profoundly affected by microbial community structure and function. Bile acids and the composition of the bile acid pool have historically been hypothesized to be associated with several disease states, including recurrent Clostridium difficile infection, inflammatory bowel diseases, metabolic syndrome, and several cancers. Recently, however, emphasis has been placed on how microbial communities in the dysbiotic gut may alter the bile acid pool to potentially cause or mitigate disease onset. This review highlights the current understanding of the interactions between the gut microbial community, bile acid biotransformation, and disease states, and addresses future directions to better understand these complex associations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Artificial sweeteners induce glucose intolerance by altering the gut microbiota
Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., Israeli, D., Zmora, N., Gilad, S., Weinberger, A., et al. (2014) · Nature · doi:10.1038/nature13793 · Cited by 2,067 · cited 1×
“…microbiota from several mouse models of obesity into germ-free animals frequently recapitulates the disease phenotype, including weight and fat gain as well as glucose intolerance and triglyceride abnormalities (Turnbaugh et al. 2006; Vijay- Kumar et al. 2010; Cox et al. 2014; Suez et al. 2014).”
BackgroundDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., Kim, S. G., Li, H., Gao, Z., Mahana, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.052 · Cited by 1,859
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,790
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., & Staels, B. (2009) · Physiological Reviews · doi:10.1152/physrev.00010.2008 · Cited by 1,678
An ecological and evolutionary perspective on human–microbe mutualism and disease
Dethlefsen, L., McFall-Ngai, M., & Relman, D. A. (2007) · Nature · doi:10.1038/nature06245 · Cited by 1,660
Bile acids: regulation of synthesis
Chiang, J. Y. L. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900010-jlr200 · Cited by 1,515
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation
Browne, H. P., Forster, S. C., Anonye, B. O., Kumar, N., Neville, B. A., Stares, M. D., Goulding, D., & Lawley, T. D. (2016) · Nature · doi:10.1038/nature17645 · Cited by 1,299
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 2×
“In a mouse model, biliary duct ligation resulted in overgrowth of aerobic and anaerobic bacteria in the ileum and cecum, but this overgrowth could be blocked by activation of FXRα with the agonist GW4064 (Inagaki et al. 2006).”
BackgroundJones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098
The Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 982
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974
Mudaliar, S., Henry, R. R., Sanyal, A. J., Morrow, L., Marschall, H., Kipnes, M., Adorini, L., Sciacca, C. I., Clopton, P., Castelloe, E., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.042 · Cited by 931 · cited 2×
“…diseases states Altered bile acid pool composition has been associated with several disease states, including recurrent Cl. difficile infection (Wilson 1983), inflammatory bowel diseases (Cima and Pemberton 2001), metabolic syndrome (Mudaliar et al. 2013), and cancers (Nagengast et al. 1995).”
BackgroundConnecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918
Swidsinski, A., Weber, J., Loening-Baucke, V., Hale, L. P., & Lochs, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3380-3389.2005 · Cited by 894 · cited 1×
“It is well established that the fecal and intestinal mucosal microbiota of human patients with IBD, particularly ileal Crohn's disease, are highly altered compared to healthy individuals (Swidsinski et al. 2005; Frank et al. 2007; Sokol et al. 2008; Willing et al. 2009).”
BackgroundGadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 1×
“A recent study revealed that treatment with an FXR agonist is protective in mouse models of chemically induced colitis (Gadaleta et al. 2011).”
BackgroundMeta‐analyses of human gut microbes associated with obesity and IBD
Walters, W. A., Xu, Z., & Knight, R. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.039 · Cited by 836
Russell, D. W., & Setchell, K. D. R. (1992) · Biochemistry · doi:10.1021/bi00135a001 · Cited by 819
Garrett, W. S., Gallini, C. A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M. L., Punit, S., Karlsson, M., Bry, L., Glickman, J. N., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.004 · Cited by 788
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.003 · Cited by 781
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Hamilton, M. J., Weingarden, A. R., Sadowsky, M. J., & Khoruts, A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.482 · Cited by 738
Self-citationHigh-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., et al. (2009) · Hepatology · doi:10.1002/hep.23082 · Cited by 720
Bile Salts and Glycine as Cogerminants for Clostridium difficile Spores
Sorg, J. A., & Sonenshein, A. L. (2008) · Journal of Bacteriology · doi:10.1128/jb.01765-07 · Cited by 711
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 696
Bile acids as regulatory molecules
Hylemon, P. B., Zhou, H., Pandak, W. M., Ren, S., Gil, G., & Dent, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900007-jlr200 · Cited by 694 · cited 3×
“acids is shown in Table 1, and these processes have been thoroughly reviewed (Nguyen and Bouscarel 2008; Hylemon et al. 2009).”
BackgroundThe bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655
Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649
Self-citationSoetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S., & Blackstone, M. O. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.125367 · Cited by 623
Bile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
Gut microbiota disturbance during antibiotic therapy: a multi-omic approach
Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., Otto, W., Rojo, D., Bargiela, R., von Bergen, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303184 · Cited by 605
Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut
Joyce, S. A., MacSharry, J., Casey, P. G., Kinsella, M., Murphy, E. F., Shanahan, F., Hill, C., & Gahan, C. G. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323599111 · Cited by 604
Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome
Sze, M. A., & Schloss, P. D. (2016) · mBio · doi:10.1128/mbio.01018-16 · Cited by 600 · cited 2×
“2006), but these findings have been recently challenged (Walters et al. 2014; Sze and Schloss 2016).”
BackgroundResultBuffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.05496-11 · Cited by 596 · cited 1×
“In mouse models (Robinson and Young 2010; Buffie et al. 2012; Pérez-Cobas et al. 2013) and humans (Dethlefsen and Relman 2011), antibiotics radically alter the composition of the colonic microbiota as well as its metabolic state.”
BackgroundPrimary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 592
Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
Vrieze, A., Out, C., Fuentes, S., Jonker, L., Reuling, I., Kootte, R. S., van Nood, E., Holleman, F., Knaapen, M., Romijn, J. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.034 · Cited by 578
Pardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J., & Lindor, K. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50156 · Cited by 562
Understanding the mechanisms of faecal microbiota transplantation
Khoruts, A., & Sadowsky, M. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.98 · Cited by 561
Self-citationRegulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 546
The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism
Claudel, T., Staels, B., & Kuipers, F. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178994.21828.a7 · Cited by 504
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial
Beuers, U., Spengler, U., Kruis, W., Aydemir, Ü., Wiebecke, B., Heldwein, W., Weinzierl, M., Pape, G. R., Sauerbruch, T., & Paumgartner, G. (1992) · Hepatology · doi:10.1002/hep.1840160315 · Cited by 448
Weingarden, A. R., Chen, C., Bobr, A., Yao, D., Lu, Y., Nelson, V. M., Sadowsky, M. J., & Khoruts, A. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00282.2013 · Cited by 423
Self-citationHigh lifetime risk of cancer in primary sclerosing cholangitis
Claessen, M. M. H., Vleggaar, F. P., Tytgat, K. M. A. J., Siersema, P. D., & van Buuren, H. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.013 · Cited by 412
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 385
Primary Sclerosing Cholangitis
(2007) · Gastroenterology Nursing · doi:10.1097/01.sga.0000267930.44372.16 · Cited by 382
FÆCAL BILE-ACIDS AND CLOSTRIDIA IN PATIENTS WITH CANCER OF THE LARGE BOWEL
Hill, M. J., Drasar, B. S., Williams, R. E. O., Meade, T. W., Cox, A. G., Simpson, J. E. P., & Morson, B. C. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91556-1 · Cited by 378
Armstrong, M. J., & Carey, M. C. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38175-x · Cited by 368
Role of bile acids in colorectal carcinogenesis
Nagengast, F. M., Grubben, M. J. A. L., & van Munster, I. P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00216-6 · Cited by 351
Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
Ridlon, J. M., Alves, J. M., Hylemon, P. B., & Bajaj, J. S. (2013) · Gut Microbes · doi:10.4161/gmic.25723 · Cited by 336
Sorg, J. A., & Sonenshein, A. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00610-10 · Cited by 332
Taurocholic acid metabolism by gut microbes and colon cancer
Ridlon, J. M., Wolf, P. G., & Gaskins, H. R. (2016) · Gut Microbes · doi:10.1080/19490976.2016.1150414 · Cited by 327
Hamilton, M. J., Weingarden, A. R., Unno, T., Khoruts, A., & Sadowsky, M. J. (2013) · Gut Microbes · doi:10.4161/gmic.23571 · Cited by 315
Self-citationHohenester, S., de Buy Wenniger, L. M., Paulusma, C. C., van Vliet, S. J., Jefferson, D. M., Oude Elferink, R. P., & Beuers, U. (2012) · Hepatology · doi:10.1002/hep.24691 · Cited by 315
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile
Wilson, K. H., Kennedy, M. J., & Fekety, F. R. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.15.3.443-446.1982 · Cited by 313
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Görg, B., Selbach, O., Häussinger, D., & Kubitz, R. (2007) · Hepatology · doi:10.1002/hep.21458 · Cited by 310
Significance of bile salt hydrolytic activities of lactobacilli
De Smet, I., Van Hoorde, L., Vande Woestyne, M., Christiaens, H., & Verstraete, W. (1995) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1995.tb03140.x · Cited by 307
Chiang, J. Y. L., Kimmel, R., Weinberger, C., & Stroup, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10918 · Cited by 304
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Porez, G., Prawitt, J., Gross, B., & Staels, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r024794 · Cited by 286
Bile Salt Hydrolase of Bifidobacterium longum —Biochemical and Genetic Characterization
Tanaka, H., Hashiba, H., Kok, J., & Mierau, I. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.6.2502-2512.2000 · Cited by 285
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212494599 · Cited by 281
Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.156 · Cited by 268
Begley, M., Sleator, R. D., Gahan, C. G. M., & Hill, C. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.894-904.2005 · Cited by 263
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Boonstra, K., van Erpecum, K. J., van Nieuwkerk, K. M. J., Drenth, J. P. H., Poen, A. C., Witteman, B. J. M., Tuynman, H. A. R. E., Beuers, U., & Ponsioen, C. Y. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22938 · Cited by 262
Phase III Trial of Ursodeoxycholic Acid To Prevent Colorectal Adenoma Recurrence
Alberts, D. S., Martínez, M. E., Hess, L. M., Einspahr, J. G., Green, S. B., Bhattacharyya, A. K., Guillen, J., Krutzsch, M., Batta, A. K., Salen, G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji144 · Cited by 247
Britton, R. A., & Young, V. B. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.04.001 · Cited by 240
How bile acids confer gut mucosal protection against bacteria
Hofmann, A. F., & Eckmann, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600780103 · Cited by 237
Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment
Burns, M. B., Lynch, J., Starr, T. K., Knights, D., & Blekhman, R. (2015) · Genome Medicine · doi:10.1186/s13073-015-0177-8 · Cited by 231 · cited 1×
“…and colorectal cancer has been reviewed (Dulal and Keku 2014; Nistal et al. 2015) and Burns and colleagues have identified specific bacterial species that are correlated with colorectal cancer and that the gut microbiota play a pivotal role in cancer development or progression (Burns et al. 2015).”
Färkkilä, M., Karvonen, A., Nurmi, H., Nuutinen, H., Taavitsainen, M., Pikkarainen, P., & Kärkkäinen, P. (2004) · Hepatology · doi:10.1002/hep.20457 · Cited by 218
Khoruts, A., Rank, K. M., Newman, K. M., Viskocil, K., Vaughn, B. P., Hamilton, M. J., & Sadowsky, M. J. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.02.018 · Cited by 213
Self-citationHeuman, D. M., Pandak, M. W., Hylemon, P. B., & Vlahcevic, R. Z. (1991) · Hepatology · doi:10.1002/hep.1840140527 · Cited by 211
Schultz, M., Tonkonogy, S. L., Sellon, R. K., Veltkamp, C., Godfrey, V. L., Kwon, J., Grenther, W. B., Balish, E., Horak, I., & Sartor, R. B. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1461 · Cited by 200
Chenodeoxycholate Is an Inhibitor of Clostridium difficile Spore Germination
Sorg, J. A., & Sonenshein, A. L. (2009) · Journal of Bacteriology · doi:10.1128/jb.01260-08 · Cited by 199
Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile
Giel, J. L., Sorg, J. A., Sonenshein, A. L., & Zhu, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008740 · Cited by 194
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012) · mBio · doi:10.1128/mbio.00338-12 · Cited by 191
Wilson, K. H. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.4.1017-1019.1983 · Cited by 186
The bile acid membrane receptor TGR5: a valuable metabolic target
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Digestive Diseases · doi:10.1159/000324126 · Cited by 185
Zárate, G., Chaia, A. P., González, S., & Oliver, G. (2000) · Journal of Food Protection · doi:10.4315/0362-028x-63.9.1214 · Cited by 176
Weingarden, A. R., Dosa, P. I., DeWinter, E., Steer, C. J., Shaughnessy, M. K., Johnson, J. R., Khoruts, A., & Sadowsky, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147210 · Cited by 170
Self-citationFXR: a promising target for the metabolic syndrome?
Cariou, B., & Staels, B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.002 · Cited by 168
Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
Thomas, C., Auwerx, J. H., & Schoonjans, K. (2008) · Thyroid · doi:10.1089/thy.2007.0255 · Cited by 167
Ursodeoxycholic acid for primary sclerosing cholangitis
Chazouillères, O., Poupon, R., Capron, J.-P., Metman, E.-H., Dhumeaux, D., Amouretti, M., Couzigou, P., Labayle, D., & Trinchet, J.-C. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90281-u · Cited by 165
Bile acids and signal transduction: Role in glucose homeostasis
Nguyen, A., & Bouscarel, B. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.06.014 · Cited by 165
Miyake, J. H., Wang, S.-L., & Davis, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000275200 · Cited by 162
Antibiotic administration alters the community structure of the gastrointestinal microbiota
Robinson, C. J., & Young, V. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12614 · Cited by 161
Voronina, S., Longbottom, R., Sutton, R., Petersen, O. H., & Tepikin, A. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.017525 · Cited by 160
Wells, J. E., & Hylemon, P. B. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.3.1107-1113.2000 · Cited by 154
Ridlon, J. M., & Hylemon, P. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m020313 · Cited by 151
Hydroxysteroid dehydrogenases (HSDs) in bacteria – A bioinformatic perspective
Kisiela, M., Skarka, A., Ebert, B., & Maser, E. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.08.002 · Cited by 148
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.05.004 · Cited by 145
Kumar, R. S., Brannigan, J. A., Prabhune, A. A., Pundle, A. V., Dodson, G. G., Dodson, E. J., & Suresh, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604172200 · Cited by 143
Fang, Y., Han, S. I., Mitchell, C., Gupta, S., Studer, E. J., Grant, S., Hylemon, P. B., & Dent, P. (2004) · Hepatology · doi:10.1002/hep.1840400427 · Cited by 140
Weingarden, A. R., Chen, C., Zhang, N., Graiziger, C. T., Dosa, P. I., Steer, C. J., Shaughnessy, M. K., Johnson, J. R., Sadowsky, M. J., & Khoruts, A. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000427 · Cited by 135
Self-citationGut Microbiome and Colorectal Adenomas
Dulal, S., & Keku, T. O. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000050 · Cited by 134
Clostridium difficileInfection: A Comprehensive Review
Kachrimanidou, M., & Malisiovas, N. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.556598 · Cited by 129
Bile Salt Activation of Stress Response Promoters in Escherichia coli
Bernstein, C., Bernstein, H., Payne, C. M., Beard, S. E., & Schneider, J. (1999) · Current Microbiology · doi:10.1007/s002849900420 · Cited by 129
Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?
Ross, R. K., Hartnett, N., Bernstein, L., & Henderson, B. E. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.29 · Cited by 127
Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling
Dossa, A. Y., Escobar, O. H., Golden, J. M., Frey, M. R., Ford, H. R., & Gayer, C. P. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00065.2015 · Cited by 126
Kandell, R. L., & Bernstein, C. (1991) · Nutrition and Cancer · doi:10.1080/01635589109514161 · Cited by 118
The history of genetics in inflammatory bowel disease.
Ek, W. E., D’Amato, M., & Halfvarson, J. (2014) · Europe PMC (PubMed Central) · Cited by 118
Boever, P. D., Wouters, R., Verschaeve, L., Berckmans, P., Schoeters, G. E. R., & Verstraete, W. (2000) · Applied Microbiology and Biotechnology · doi:10.1007/s002530000330 · Cited by 117
Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids.
Batta, A. K., Salen, G., Arora, R., Shefer, S., Batta, M., & Person, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38535-7 · Cited by 116
Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota
Nistal, E., Fernández-Fernández, N., Vivas, S., & Olcoz, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00220 · Cited by 113
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Brandt, L. J., & Reddy, S. S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318222e603 · Cited by 109
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
Hu, X., Bonde, Y., Eggertsen, G., & Rudling, M. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12140 · Cited by 106
Yoshimoto, T., Higashi, H., Kanatani, A., Lin, X.-S., Nagai, H., Ōyama, H., Kurazono, K., & Tsuru, D. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.7.2173-2179.1991 · Cited by 102
Ishizawa, M., Matsunawa, M., Adachi, R., Uno, S., Ikeda, K., Masuno, H., Shimizu, M., Iwasaki, K., Yamada, S., & Makishima, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700293-jlr200 · Cited by 102
Heterogeneity of bile salts resistance in the Lactobacillus isolates of a probiotic consortium
Chateau, N., Deschamps, A. M., & Sassi, A. H. (1994) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.1994.tb00796.x · Cited by 101
Bas-Prior, J. M. D., Ricketts, M., Vaqué, M., Sala, E., Quesada, H., Ardèvol, A., Salvadó, M. J., Blay, M., Arola, L., Moore, D. D., et al. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800364 · Cited by 101
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Bilz, S., Samuel, V. T., Morino, K., Savage, D. B., Choi, C. S., & Shulman, G. I. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2005 · Cited by 97
Duodenogastric reflux and gastric stump carcinoma
Kondo, K. (2002) · Gastric Cancer · doi:10.1007/s101200200002 · Cited by 94
Sobczak, M., Fabisiak, A., Murawska, N., Wesołowska, E., Wierzbicka, P., Wlazłowski, M., Wójcikowska, M., Zatorski, H., Zwolińska, M., & Fichna, J. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.04.005 · Cited by 93
Yang, Y., Zhang, M., Eggertsen, G., & Chiang, J. Y. L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00186-5 · Cited by 92
Wells, J. E., Berr, F., Thomas, L. A., Dowling, R. H., & Hylemon, P. B. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80183-x · Cited by 91
Chen, W., & Chiang, J. Y. L. (2003) · Gene · doi:10.1016/s0378-1119(03)00631-0 · Cited by 90
Gnewuch, C., Liebisch, G., Langmann, T., Dieplinger, B., Mueller, T., Haltmayer, M., Dieplinger, H., Zahn, A., Stremmel, W., Rogler, G., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3134 · Cited by 88
Sinha, J., Chen, F., Miloh, T., Burns, R. C., Zhisheng, Y., & Shneider, B. L. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90343.2008 · Cited by 88
Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria
Eldere, J. V., Celis, P., Pauw, G. D., Lesaffre, E., & Eyssen, H. (1996) · Applied and Environmental Microbiology · doi:10.1128/aem.62.2.656-661.1996 · Cited by 86
Ferrandi, E. E., Bertolesi, G. M., Polentini, F., Negri, A. L., Riva, S., & Monti, D. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3798-x · Cited by 82
Delpino, M. V., Marchesini, M. I., Estein, S. M., Comerci, D. J., Cassataro, J., Fossati, C. A., & Baldi, P. C. (2006) · Infection and Immunity · doi:10.1128/iai.00952-06 · Cited by 82
Baron, S. F., Franklund, C. V., & Hylemon, P. B. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.15.4558-4569.1991 · Cited by 80
Lewin, J. S., Gillenwater, A. M., Garrett, J. D., et al. (2003) · Cancer · doi:10.1002/cncr.11158 · Cited by 80
Macdonald, I. A., Rochon, Y. P., Hutchison, D. M., & Holdeman, L. V. (1982) · Applied and Environmental Microbiology · doi:10.1128/aem.44.5.1187-1195.1982 · Cited by 80
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · PubMed · doi:10.1097/01.hjr.0000060840.46106.ea · Cited by 77
3α-, 7α- And 12α-hydroxysteroid dehydrogenase activities from Clostridium perfringens
Macdonald, I. A., Meier, E. C., Mahony, D. E., & Costain, G. A. (1976) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(76)90086-2 · Cited by 75
Bile Salt 3α- and 12α-Hydroxysteroid Dehydrogenases from Eubacterium lentum and Related Organisms
MacDonald, I. A., Jellett, J. F., Mahony, D. E., & Holdeman, L. V. (1979) · Applied and Environmental Microbiology · doi:10.1128/aem.37.5.992-1000.1979 · Cited by 73
Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines
Tucker, O., Dannenberg, A. J., Yang, E. K., & Fahey, T. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh010 · Cited by 70
Modulation of Protein Kinase C by Taurolithocholic Acid in Isolated Rat Hepatocytes
Beuers, U. H., Probst, I., Soroka, C. J., Boyer, J. L., Kullak-Ublick, G. A., & Paumgartner, G. (1999) · Hepatology · doi:10.1002/hep.510290227 · Cited by 69
Bile acids, farnesoid X receptor, atherosclerosis and metabolic control
Kuipers, F., Stroeve, J. H. M., Caron, S., & Staels, B. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3281338d08 · Cited by 68
Wells, J. E., Williams, K. B., Whitehead, T. R., Heuman, D. M., & Hylemon, P. B. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00115-3 · Cited by 68
Centuori, S. M., & Martinez, J. D. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3190-7 · Cited by 68
Bouscarel, B. E., Kroll, S., & Fromm, H. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900433 · Cited by 66
Stamp, D. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00125-1 · Cited by 63
The metabolism of primary, 7-oxo, and 7 beta-hydroxy bile acids by Clostridium absonum.
Sutherland, J. D., & Macdonald, I. A. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38105-0 · Cited by 62
Ogilvie, L. A., & Jones, B. V. (2012) · Gut · doi:10.1136/gutjnl-2012-302137 · Cited by 61
Coleman, J. P., Hudson, L. L., & Adams, M. J. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.16.4865-4874.1994 · Cited by 55
Sherrod, J. A., & Hylemon, P. B. (1977) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(77)90031-5 · Cited by 52
Lau, B. W., Colella, M., Ruder, W. C., Ranieri, M., Curci, S., & Hofer, A. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.046 · Cited by 51
Mallonee, D. H., Lijewski, M. A., & Hylemon, P. B. (1995) · Current Microbiology · doi:10.1007/bf00295498 · Cited by 51
Multi-omics analysis of inflammatory bowel disease
Huang, H., Vangay, P., McKinlay, C. E., & Knights, D. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.014 · Cited by 51
Gothe, F., Beigel, F., Rust, C., Hajji, M. S., Koletzko, S., & Freudenberg, F. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.02.027 · Cited by 44
Edenharder, R., & Schneider, J. S. (1985) · Applied and Environmental Microbiology · doi:10.1128/aem.49.4.964-968.1985 · Cited by 42
Partial Ileal Bypass for Hypercholesterolemia
Buchwald, H., Stoller, D. K., Campos, C. T., Matts, J. P., & Varco, R. L. (1990) · Annals of Surgery · doi:10.1097/00000658-199009000-00010 · Cited by 39
Thompson, P. A., Wertheim, B. C., Roe, D. J., Ashbeck, E. L., Jacobs, E. T., Lance, P., Martínez, M. E., & Alberts, D. S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0234 · Cited by 38
Potential regulatory role of the farnesoid X receptor in the metabolic syndrome
Durán-Sandoval, D., Cariou, B., Fruchart, J., & Staels, B. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.018 · Cited by 37
Harris, J., & Hylemon, P. B. (1978) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(78)90060-7 · Cited by 35
Clostridium difficile Infection in Patients With Ileal Pouches
Seril, D. N., & Shen, B. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.22 · Cited by 33
Portal vein bile acids in patients with severe inflammatory bowel disease
Holzbach, R., Marsh, M. E., Freedman, M. R., Fazio, V. W., Lavery, I. C., & Jagelman, D. G. (1980) · Gut · doi:10.1136/gut.21.5.428 · Cited by 32
TGR5 as a Therapeutic Target for Treating Obesity
Zhong, M. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790980576 · Cited by 31
Edenharder, R., Pfützner, A., & Hammann, R. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90272-5 · Cited by 31
Albalak, A., Zeidel, M. L., Zucker, S. D., Jackson, A. A., & Donovan, J. M. (1996) · Biochemistry · doi:10.1021/bi960497i · Cited by 31
Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines
Shah, S. A., Looby, E., Volkov, Y., Long, A., & Kelleher, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.015 · Cited by 30
Chignard, N., Mergey, M., Veissière, D., Poupon, R. Y., Capeau, J., Parc, R., Paul, A., & Housset, C. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00292.2002 · Cited by 29
The Metabolic Syndrome: Targeting Dyslipidaemia to Reduce Coronary Risk
Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670301000207 · Cited by 27
Effect of bile on the $\beta$-galactosidase activity of dairy propionibacteria
Zárate, G., González, S., Chaia, A. P., & Oliver, G. (2000) · Le Lait · doi:10.1051/lait:2000125 · Cited by 26
Yamaoka‐Tojo, M., Tojo, T., & Izumi, T. (2008) · Current Vascular Pharmacology · doi:10.2174/157016108785909698 · Cited by 23
Characterization of NADP-dependent 12β-hydroxysteroid dehydrogenase from Clostridium paraputrificum
Edenharder, R., & Pfützner, A. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90266-4 · Cited by 22
Edenharder, R., Pfützner, M., & Hammann, R. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90061-1 · Cited by 22
Ji, W., Chen, Y., Zhang, H., Zhang, X., Li, Z., & Yu, Y. (2013) · Microbiological Research · doi:10.1016/j.micres.2013.07.009 · Cited by 21
Bile acids as drugs: principles, mechanisms of action and formulations.
Hofmann, A. F. (1995) · PubMed · Cited by 20
LUV's lipid composition modulates diffusion of bile acids
Hofmann, M. W., Schumann, C., Zimmer, G., Henzel, K., Locher, U., & Leuschner, U. (2001) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(01)00131-1 · Cited by 19
Akao, T., Taiko, A., Hattori, M., Namba, T., & Kobashi, K. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90028-2 · Cited by 16
Clinical inquiry: what risk factors contribute to C difficile diarrhea?
Fashner, J., Garcia, M., Ribble, L., & Crowell, K. (2011) · PubMed · Cited by 12
Optimizing post-operative Crohn's disease treatment.
Domènech, E., Mañosa, M., Lobatón, T., & Cabré, E. (2014) · Europe PMC (PubMed Central) · Cited by 11
Cited by
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., Agdashian, D., Terabe, M., Berzofsky, J. A., Fako, V., et al. (2018) · Science · doi:10.1126/science.aan5931 · Cited by 1,508
Oliphant, K., & Allen-Vercoe, E. (2019) · Microbiome · doi:10.1186/s40168-019-0704-8 · Cited by 1,327
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Song, X., Sun, X., Oh, S. F., Wu, M., Zhang, Y., Zheng, W., Geva-Zatorsky, N., Jupp, R., Mathis, D., Benoist, C., et al. (2020) · Nature · doi:10.1038/s41586-019-1865-0 · Cited by 1,024
Metadata
- Authors
- Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2016-11-25
- Volume
- 101
- Issue
- 1
- Pages
- 47-64
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W2552283579
- Cited by
- 581
- References
- 189
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.